Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

6.05

-0.28 (-4.42%)

At close: Jun 5, 2025, 4:00 PM

6.01

-0.04 (-0.66%)

After-hours: Jun 5, 2025, 4:18 PM EDT

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $329.20 million as of June 5, 2025. Its market cap has increased by 13.20% in one year.

Market Cap

329.20M

Enterprise Value

857.95M

1-Year Change

13.20%

Ranking

#3228

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $329.20M, an increase of 2.62%. That is a compound annual growth rate of 0.14%.

Market Cap History

Date	Market Cap	% Change
Jun 4, 2025	343.60M	-33.67%
Dec 31, 2024	518.00M	316.06%
Dec 29, 2023	124.50M	-78.87%
Dec 30, 2022	589.20M	-74.81%
Dec 31, 2021	2.34B	-50.75%
Dec 31, 2020	4.75B	70.50%
Dec 31, 2019	2.79B	-7.78%
Dec 31, 2018	3.02B	57.00%
Dec 29, 2017	1.92B	44.63%
Dec 30, 2016	1.33B	-14.64%
Dec 31, 2015	1.56B	52.38%
Dec 31, 2014	1.02B	22.29%
Dec 31, 2013	836.10M	45.38%
Dec 31, 2012	575.10M	-5.00%
Dec 30, 2011	605.40M	-25.67%
Dec 31, 2010	814.50M	94.58%
Dec 31, 2009	418.60M	-46.42%
Dec 31, 2008	781.20M	419.07%
Dec 31, 2007	150.50M	-50.82%
Dec 29, 2006	306.00M	-4.61%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	690.37B
Johnson & Johnson	370.13B
AbbVie	333.89B
Novo Nordisk	315.80B
UnitedHealth Group	273.29B
Abbott Laboratories	232.62B
Novartis AG	226.74B
AstraZeneca	223.00B

Market Cap Rankings